Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Rheumatology
•
Osteoarthritis
•
General Rheumatology
Do you consider metformin as a disease-modifying adjunct in the management of patients with OA, particularly in those with comorbid metabolic syndrome or type 2 diabetes?
Metformin for Knee Osteoarthritis in Patients With Overweight or Obesity A Randomized Clinical Trial
Related Questions
How do you approach prescribing analgesics for osteoarthritis related pain in patients with comorbidities, particularly given new evidence that even acetaminophen is associated with increased risk of GI complications (bleeding, peptic ulcer disease), heart failure and CKD?
Is there any data to support a 3rd course of LDRT for someone with osteoarthritis or tendinitis?
How do you approach diagnosis in a patient with inflammatory joint symptoms and isolated bilateral CMC joint erosions on x-ray imaging?
How often do you recommend ophthalmologic screening exams for patients with sarcoidosis?
In a patient with a history of parathyroidectomy (due to primary hyperparathyroidism) with low T- scores and high risk of fractures, is there any contraindication to give teriparatide/Forteo if PTH is in normal range after surgery?
Would you ever consider retreatment with an antiresorptive medication in a patient with a remote history of atypical fracture attributed to an oral bisphosphonate?
Would you add immunosuppression for recurrent calcium kidney stones in a patient with sarcoidosis?
Can you see false positive autoimmune serologies in patients with a history of stem cell transplant and chronic graft vs host disease?
Have you utilized JAK inhibitors in patients on dialysis?
What is the interpretation of an IGRA with positive TB wells and negative nil and negative mitogen wells?
